載入中
NASDAQHealthcareDrug Manufacturers - Specialty & Generic
最新資料
US$1.69
−US$0.04 · -2.31%
Zhengye Biotechnology Holding Limited specializes in the creation, manufacturing, and commercialization of animal health immunizations. The company primarily supplies the Chinese agricultural sector with vaccines tailored for a broad spectrum of farm animals, including swine, bovines, goats, ovines, and poultry. Additionally, its product range encompasses inoculations for canines. Beyond its domestic reach, the firm also distributes its offerings to international markets, notably exporting to Vietnam, Pakistan, and Egypt. Established in 2004, this enterprise bases its principal operations in Jilin, China, and operates as a subsidiary entity of Securingium Holding Limited.
前收盤價
US$1.69
−US$0.04 · -2.31%
盤後
US$1.70
+US$0.01 · +0.59%
10月12日 下午7:59 ET
盤中時間採用ET。市場資料可能有所延遲。
Zhengye Biotechnology Holding Limited specializes in the creation, manufacturing, and commercialization of animal health immunizations. The company primarily supplies the Chinese agricultural sector with vaccines tailored for a broad spectrum of farm animals, including swine, bovines, goats, ovines, and poultry. Additionally, its product range encompasses inoculations for canines. Beyond its domestic reach, the firm also distributes its offerings to international markets, notably exporting to Vietnam, Pakistan, and Egypt. Established in 2004, this enterprise bases its principal operations in Jilin, China, and operates as a subsidiary entity of Securingium Holding Limited.
日內區間
目前US$1.69
52週區間
目前US$1.69
盤中時間採用ET。市場資料可能有所延遲。
GoAI 評分
賣出
估值
45
合理估值
情緒
49
多空交錯
風險
69
高風險
動能
21
動能減弱
完整 GoAI 研究
繼續查看更深入的依據、催化因素和風險。
Zhengye Biotechnology Holding Limited specializes in the creation, manufacturing, and commercialization of animal health immunizations. The company primarily supplies the Chinese agricultural sector with vaccines tailored for a broad spectrum of farm animals, including swine, bovines, goats, ovines, and poultry. Additionally, its product range encompasses inoculations for canines. Beyond its domestic reach, the firm also distributes its offerings to international markets, notably exporting to Vietnam, Pakistan, and Egypt. Established in 2004, this enterprise bases its principal operations in Jilin, China, and operates as a subsidiary entity of Securingium Holding Limited.
日內區間
目前US$1.69
52週區間
目前US$1.69
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（CNY） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 1.16億 CNY | 1.86億 CNY | 2.12億 CNY | 2.6億 CNY | 2.14億 CNY |
| 銷貨成本 | 9249.3萬 CNY | 9506.1萬 CNY | 8179.6萬 CNY | 1.07億 CNY | 8867.4萬 CNY |
| 毛利 | 2386.9萬 CNY | 9129.5萬 CNY | 1.3億 CNY | 1.54億 CNY | 1.25億 CNY |
| 研究與開發 | 1801.3萬 CNY | 1279.4萬 CNY | 1190.1萬 CNY | 1342.4萬 CNY | 1137萬 CNY |
| 銷售、一般及管理費用 | 7492.4萬 CNY | 6384.4萬 CNY | 6663.4萬 CNY | 6355.8萬 CNY | 5819.4萬 CNY |
| 營業費用 | 9212.3萬 CNY | 7485.6萬 CNY | 8486.9萬 CNY | 8768.5萬 CNY | 7301萬 CNY |
| 利息收入 | 9.6萬 CNY | 23.1萬 CNY | 31.2萬 CNY | 11.4萬 CNY | 11.2萬 CNY |
| 利息支出 | 340萬 CNY | 404.3萬 CNY | 442.3萬 CNY | 283.9萬 CNY | 104.6萬 CNY |
| 折舊和攤銷 | 2595.5萬 CNY | 2416.3萬 CNY | 2391.2萬 CNY | 1880萬 CNY | 1601.2萬 CNY |
| 營業利益 | −6825.4萬 CNY | 1643.9萬 CNY | 4498.6萬 CNY | 6583.4萬 CNY | 5238.3萬 CNY |
| 淨利 | −6978.4萬 CNY | 1131.1萬 CNY | 3145.7萬 CNY | 4673.5萬 CNY | 3895.9萬 CNY |
公司資料更新於 2026年10月13日。
已公布業績及可用的市場共識預估。
已公布業績及可用的市場共識預估。
AI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
